Plan Comparative Stability Studies for Biosimilars vs. Reference Product
Understanding the Tip: Why comparative stability is crucial in biosimilar development: Unlike generics, biosimilars must demonstrate similarity to a reference biologic across quality, safety, and efficacy attributes—including degradation behavior. Comparative stability studies provide critical evidence that the biosimilar maintains quality over time in a manner equivalent to the reference. These studies help confirm that the…
Read More “Plan Comparative Stability Studies for Biosimilars vs. Reference Product” »
